Article List

WPRIM Management System> DCMS> Journal of Movement Disorders> 2022> 15

Volume: 15

1. Presynaptic Dopaminergic Dysfunction Was Overestimated in Huntington’s Disease Presenting as Young Age-Onset Parkinsonism	Page:293—295
2. Teaching Research Methods to Young Neurologists: The Erice International Courses	Page:227—231
3. Potential Link Between Cognition and Motor Reserve in Patients With Parkinson’s Disease	Page:249—257
4. Mosapride-Induced Movement Disorders	Page:273—276
5. Catatonia in Hospitalized Patients With COVID-19: An Important Clinical Finding That Should Not be Missed	Page:277—280
6. Movement Disorders Resulting From Bilateral Basal Ganglia Lesions in End-Stage Kidney Disease: A Systematic Review	Page:258—263
7. Refractory Myoclonus as a Presentation of Metabolic Stroke in A Child With Cobalamin B Methylmalonic Acidemia After Liver and Kidney Transplant	Page:281—283
8. Pallidus Stimulation for Chorea-Acanthocytosis: A Systematic Review and Meta-Analysis of Individual Data	Page:197—205
9. Semiautomated Algorithm for the Diagnosis of Multiple System Atrophy With Predominant Parkinsonism	Page:232—240
10. Long-Term Outcomes of Deep Brain Stimulation in Pantothenate Kinase-Associated Neurodegeneration-Related Dystonia	Page:241—248
11. Sensitivity of Detecting Alpha-Synuclein Accumulation in the Gastrointestinal Tract and Tissue Volume Examined	Page:264—268
12. Nearly Abolished Dopamine Transporter Uptake in a Patient With a Novel FBXO7 Mutation	Page:269—272
13. Blacksmith’s Dystonia Is Another Task-Specific Dystonia: From Past to Present	Page:284—285
14. Multiple Sclerosis-Related Paroxysmal Kinesigenic Dyskinesia: Long Term, Favorable Response to Lacosamide	Page:286—289
15. Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose	Page:290—292
16. Treatable Ataxias: How to Find the Needle in the Haystack?	Page:206—226
17. Syringomyelia Manifesting With Pseudodystonia: A Case Report	Page:175—177
18. Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy	Page:106—114
19. Labrune’s Syndrome Presenting With Stereotypy-Like Movements and Psychosis: A Case Report and Review	Page:162—166
20. A Case of AOA2 With Compound Heterozygous SETX Mutations	Page:178—180
21. Automatic Measurement of Postural Abnormalities With a Pose Estimation Algorithm in Parkinson’s Disease	Page:140—145
22. Long-Term Outcome of Hemimasticatory Spasm	Page:146—150
23. Utility of Clinical Exome Sequencing in Dystonia: A Single-Center Study From India	Page:156—161
24. Asymmetric Parkinsonism With Progressive Nigrosomal Change Secondary to Kernohan’s Notch Phenomenon	Page:184—186
25. Umami and Other Taste Perceptions in Patients With Parkinson’s Disease	Page:115—123
26. Expanding the Clinical Spectrum of RFC1 Gene Mutations	Page:167—170
27. Effect of Chelation Therapy on a Korean Patient With Brain Manganese Deposition Resulting From a Compound Heterozygous Mutation in the SLC39A14 Gene	Page:171—174
28. Pseudodystonia and Neuropathic Tremor in a Patient With Monomelic Amyotrophy	Page:181—183
29. Comment on “Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis”	Page:187—188
30. Hand Movement-Induced Eyeblink Bursts in a Patient With Parkinson’s Disease	Page:190—192
31. Acute Extrapyramidal Side Effects Following Domperidone Intake in a 48-Year-Old Female Patient: The First Genetic Alteration and Drug Interaction Characterized	Page:193—195
32. Diagnosis and Clinical Features in Autoimmune-Mediated Movement Disorders	Page:95—105
33. Development of Clinical Milestones in Parkinson’s Disease After Bilateral Subthalamic Deep Brain Stimulation	Page:124—131
34. Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson’s Disease	Page:132—139
35. Re: Comment on “Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis”	Page:189—189
36. Cortical Subarachnoid Hemorrhage Presenting with Hemibody Dystonic Myoclonus: An Illustrative Case	Page:75—76
37. Resilience and Trauma among Patients with Parkinson’s Disease during the COVID-19 Pandemic	Page:77—79
38. Opsoclonus-Myoclonus Syndrome as a Heralding Feature of Scrub Typhus: An Illustrative Case with a Video Vignette	Page:80—82
39. Dancing Feet Dyskinesia in a Patient with GBA-PD	Page:83—85
40. Constipation is Associated With Mild Cognitive Impairment in Patients With de novo Parkinson’s Disease	Page:38—42
41. COVID-19 Associated Acute Necrotizing Encephalopathy Presenting as Parkinsonism and Myorhythmia	Page:89—92
42. The Supplementary Motor Complex in Parkinson’s Disease	Page:21—32
43. Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis	Page:66—70
44. Comment on “Chorea as a Presentation of SARS-CoV-2 Encephalitis: A Clinical Case Report”	Page:93—93
45. Re: Comments on “Chorea as a Presentation of SARS-CoV-2 Encephalitis: A Clinical Case Report”	Page:94—94
46. Current Status of Telemedicine for Parkinson’s Disease in Japan: A Single-Center Cross-Sectional Questionnaire Survey	Page:58—61
47. Extensive Leukoencephalopathy in Spastic Paraplegia Type 4: Possible Role of Cerebral Autosomal Arteriopathy With Subcortical Infarcts and Leukoencephelopathy	Page:71—74
48. Premonitory Urges Reconsidered: Urge Location Corresponds to Tic Location in Patients With Primary Tic Disorders	Page:43—52
49. Task-Specific Dystonia in a Professional Billiard Player	Page:86—88
50. Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy	Page:1—14
51. Dance Intervention Using the Feldenkrais Method Improves Motor, and Non-Motor Symptoms and Gait in Parkinson’s Disease: A 12-Month Study	Page:53—57
52. Deep Brain Stimulation for Cockayne Syndrome-Associated Movement Disorder	Page:62—65
53. Gene Therapy for Huntington’s Disease: The Final Strategy for a Cure?	Page:15—20
54. Association of AXIN1 With Parkinson’s Disease in a Taiwanese Population	Page:33—37